StemCyte International, Ltd.

Research StemCyte International, Ltd. (4178.TW) on Bullrun: market cap TWD 3.80B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker4178.TW
ExchangeTW
CountryTaiwan
SectorHealthcare
IndustryBiotechnology
CurrencyTWD
Market capTWD 3.80B
Financial periodQ2 2026
RevenueTWD 96.64M
Net income-TWD 51.80M
Free cash flowTWD 157.00K
Gross margin34.1%

Valuation Snapshot

latest market cap is TWD 3.80B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 3.80B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About StemCyte International, Ltd.

StemCyte International, Ltd., a biotechnology company, develops cord bloodbased cell therapies in the United States and Taiwan. The company engages in the research and development of biotechnology and cell-based new drugs; supply of cellular materials; and operation of cord blood cell banks. It also offers umbilical cord blood transplantation services; and cell products and services.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO)

Frequently asked questions

What is StemCyte International, Ltd.'s market cap?

StemCyte International, Ltd.'s market capitalization is TWD 3.80B.